Back to VP VANGUARD PORTFOLIO MANAGEMENT LLC

MYGNMYGN
2 quarters

Position history for VPVANGUARD PORTFOLIO MANAGEMENT LLC's holdings in MYRIAD GENETICS INC

Yes. Vanguard Portfolio Management holds 3,079,670 shares of MYGN (Myriad Genetics), worth $17.6M, as of its Q2 2026 13F filing. It increased the position by 497,439 shares (+19.3%) from Q1 2026. Vanguard Portfolio Management has held MYGN in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$17.6M

Current Shares

3.1M

Total Value Change

+$6M

Total Shares Change

+497,439

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.1M
+19.3%
$17.6M0.0%$5.71
33
2026-Q1
First report
2.6M
-
$11.6M0.0%$4.50
0

Other major holders of MYGN: BlackRock, Inc., BlackRock Finance, Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used